top of page

Podcast

May 21, 2025

Realising the true benefits of risk management with Brian Barnes

In this episode of Clinical Data Talks, Sylvain Berthelot welcomes Brian Barnes, Director of Risk Management Strategy at BioNTech, to explore the human and strategic dimensions of risk-based quality management (RBQM).

Drawing from his rich experience across CROs, technology vendors, and now a sponsor organisation, Brian shares how his role as a “risk assessment facilitator” reflects a broader cultural shift: developing a company-wide risk-focused mindset and moving risk management upstream into study design and operational planning.

Sylvain and Brian talk about building risk frameworks from the ground up, demonstrating return on investment for RBQM and confronting resistance and misconceptions. Brian offers practical insight into why RBQM is less about the tools and more about people, collaboration, and culture.

Tune in to discover what “good” risk management looks like and how to make it stick – across teams, trials, and organisations.

placeholder_white_300x300.jpg

Share via

See CRScube in action

Explore how our platform will elevate your team and clinical trial management.

crscube_in_action_ca.avif

Get insights straight to your inbox

img_001.avif

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

Featured resources

icon_01.png

VSPharmTech selects Pharmaron and CRScube as partners for U.S. FDA phase 2 clinical trial

VSPharmTech has selected digital clinical trial solution provider CRScube as partners for its U.S. FDA Phase 2 clinical trial of its radiation sensitizer candidate, VS-101.

icon_01.png

cubeCDMS strengthens its leadership position in G2's latest report

The recognition from G2 reflects what matters most to us: the experience of the teams on the ground.

icon_01.png

Geekfest 2025 preparation journey by APAC director Uchiyama and manager Aono

We are pleased to host CRScube Geekfest 2025, our user conference in Japan, on Monday, June 16th, 2025, for pharmaceutical companies, CROs, and academia representatives who are currently using or considering implementing CRScube’s solutions.

bottom of page